12-HETE-d8

CAT:
804-HY-113439S
Size:
25 µg (304.40 μM x 250 μL in Acetonitrile)
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
12-HETE-d8 - image 1

12-HETE-d8

  • Description:

    12-HETE-d8 is the deuterium labeled 12-HETE. 12-HETE, a major metabolic product of arachidonic acid using 12-LOX catalysis, inhibits cell apoptosis in a dose-dependent manner. 12-HETE promotes the activation and nuclear translocation of NF-κB through the integrin-linked kinase (ILK) pathway[1].12-HETE has both anti-thrombotic and pro-thrombotic effects[2]. 12-HETE is a neuromodulator[3].
  • UNSPSC:

    12352211
  • Target:

    Apoptosis
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Apoptosis
  • Field of Research:

    Inflammation/Immunology; Cardiovascular Disease
  • Concentration:

    304.40 μM * 250 μL in Acetonitrile
  • Purity:

    98.0
  • Solubility:

    10 mM in DMSO
  • Smiles:

    CCCCC/C ([2H]) =C (CC ([2H]) (/C ([2H]) =C/C ([2H]) =C (C/C ([2H]) =C (CCCC (O) =O) /[2H]) /[2H]) O) /[2H]
  • Molecular Formula:

    C20H24D8O3
  • Molecular Weight:

    328.52
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Qian Liu, et al. 12-HETE facilitates cell survival by activating the integrin-linked kinase/NF-κB pathway in ovarian cancer. Cancer Manag Res. 2018 Nov 16;10:5825-5838.|[3]Benedetta Porro, et al. Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:26-40.|[4]Aidan J Hampson, et al. 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J Neurosci. 2002 Jan 1;22 (1) :257-64.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    Solution, -20°C, 2 years
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • CAS Number:

    2525175-25-9